<DOC>
	<DOCNO>NCT01216618</DOCNO>
	<brief_summary>The study prospective , multi-center , open label , randomize ; two-arms cross study . This test protocol InsuPatch device , whose purpose improve insulin delivery blood insulin infuse use insulin-infusion pump control heating area surround point infusion .</brief_summary>
	<brief_title>Evaluation Effect InsuPatch Device Insulin Pharmacokinetics Clamp Studies</brief_title>
	<detailed_description>Fifty five ( 55 ) type 1 IDDM subject three center use MiniMed paradigm insulin pump , meet inclusion/exclusion criterion outline provide write Informed Consent enrol study . The study do subject randomize one two procedure sequence . Each subject undergo 3 procedure ( two clamp InsuPatch one clamp without InsuPatch ) thus serve his/her control . The 55 subject randomize one sequence . The order procedure select randomly perform within one month . There six Device visit start screen randomization visit , 3 clamp completion visit .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>1 . Age 18 65 year old ( include = 18 year =65 year ) 2 . Gender : men woman 3 . BMI : 1835 kg/m2 4 . Type 1 Insulin dependent diabetes use MiniMed paradigm insulin pump least six month use insulin Lispro Insulin Aspart . 5 . Diabetic subject HbA1c value 9.5 % ( include 9.5 % ) . 6 . Subject understands study requirement treatment procedure sign Informed Consent studyspecific test procedure perform 7 . Subject willing comply specify followup evaluation 1 . Pregnancy 2 . Breast feeding woman . 3 . Alcohol addiction 4 . Had CABG ( Coronary Artery Bypass Graft ) , Post MI ( Myocardial Infarction ) active Ischemic heart disease prior study date 5 . Had CVA ( cardiovascular accident ) TIA ( transient ischemic accident ) prior study 6 . Suffer uncontrolled Hypertension ( blood pressure mm HG &gt; 160 systolic &gt; 95 diastolic ) 7 . Low blood hemoglobin concentration &lt; 9 g/dL female &lt; 11g/dL male . 8 . Abnormal kidney and/ liver function test . ( If liver kidney function test parameter great 3 fold normal value . 9 . Subjects Hyperthyroidism Hypothyroidism TSH level outside normal range , TSH &gt; 5.5 mIU/L TSH &lt; 0.4 mIU/L 10 . Psychological incompetence 11 . Any clinical condition history , seem relevant principle investigator disqualify participant . 12 . Subjects diminish skin integrity 13 . Subjects heat sensitivity 14 . Subjects involve planed participate study 15 . Subjects use drug therapy control blood glucose level insulin .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>MiniMed paradigm insulin pump</keyword>
	<keyword>insulin Lispro</keyword>
	<keyword>Insulin Asprt .</keyword>
</DOC>